Orange CA 黑色素瘤临床试验
14项针对 黑色素瘤的研究正在 Orange及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
招募中2 期
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
招募中3 期
- St. Joseph Hospital Orange, Orange
- University of California Irvine, UCI Medical Center, Orange
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
招募中3 期
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- Children's Hospital of Orange County, Orange
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Children's Hospital of Orange County, Orange
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
招募中早期 I 期
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
招募中2 期
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
招募中1/2 期
- University of California Irvine, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
招募中1/2 期
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Neoadjuvant Darovasertib in Primary Uveal Melanoma
招募中3 期
- University of California Irvine Medical Center, Orange
A Study of VET3-TGI in Patients With Solid Tumors
招募中1 期
- UC Irvine Health, Orange
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
招募中2 期
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Orange
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Orange
其他城市的 黑色素瘤试验
- Houston, TX59 项研究
- New York City, NY38 项研究
- Los Angeles, CA34 项研究
- Nashville, TN33 项研究
- Pittsburgh, PA31 项研究
- Boston, MA26 项研究
- Philadelphia, PA23 项研究
- San Francisco, CA22 项研究
- Atlanta, GA21 项研究
- Durham, NC21 项研究
- St. Louis, MO21 项研究
- Columbus, OH21 项研究
Orange的其他研究
- 非小细胞肺癌25 项研究
- 转移性癌症20 项研究
- 结直肠癌16 项研究
- 卵巢癌16 项研究
- 胰腺癌15 项研究
- 乳腺癌14 项研究
- 肺癌14 项研究
- 前列腺癌14 项研究
- 肝癌（肝细胞癌）14 项研究
- 急性髓系白血病13 项研究
- 癌症（所有类型）13 项研究
- 胃癌13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。